SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
iBio has filed an exhibit containing a September 2026 corporate presentation focused on its therapeutic candidates for obesity and cardiometabolic diseases, which includes forward-…
American Tower Corporation priced $1.6 billion in senior notes due 2031, 2033, and 2036, leveraging its investment grade credit rating to raise capital.
Change Agents Corporation issued a nine-month OID promissory note for $280,000 to C/M Capital Series without SEC registration, carrying legal covenants regarding disposition and ba…
lululemon athletica inc. filed amended bylaws that explicitly permit board-chair and CEO to hold shareholder meetings solely by remote communication, a change made effective Septem…
Ingles Markets Inc has amended and restated its bylaws. The changes primarily address the corporation's registered office, principal office and related authority. The filing was su…
Dave & Buster's reported a 2.9% comparable store sales decline for Q2 2026; Adjusted EBITDA dropped to $98.9 million. The company remains focused on its Back-to-Basics strategy to …
PDS Biotechnology closed an initial $11.3 million financing round led by Nant Capital and appointed Dr. Patrick Soon-Shiong to its board, using proceeds to repay debt, fund working…
Wildfire Intermediate Holdings, a subsidiary of Magnolia Oil & Gas, priced $500 million in 7.500% Senior Notes due 2029. This new debt issuance provides the company with access to …
First Citizens BancShares entered into an underwriting agreement to sell 300,000 depositary shares for an aggregate offering size. The move reflects the company's strategy to raise…
Boot Barn announced participation in September investor conferences and reaffirmed its second-quarter same-store sales and earnings per share expectations remain within guidance.
Contineum Therapeutics announced that the MOONLIGHT-1 trial evaluating JNJ-5120/PIPE-307 did not meet its primary efficacy endpoint for major depressive disorder, though the candid…
Veracyte, Inc. has entered into a definitive agreement and plan of merger with Convergent Genomics, Inc. that will result in the latter becoming a wholly-owned subsidiary following…
Parker-Hannifin authorized $525 million of new senior notes, aiming to leverage corporate debt. The new senior notes carry a 4.75% interest rate.
Inmune Bio strengthens commercialization and strategy capabilities with the appointment of two executives from Sanofi and biotech leadership roles ahead of Ebstrocel's potential la…
Emergent BioSolutions issued a presentation for its President and CEO at the 28th Annual Global Investment Conference, outlining strategic objectives. The company provided safe har…
Yarrow Bioscience agreed to underwritten sale of 5.8M shares via Jefferies and others, with possible additional shares.
The company reported quarterly revenue and net loss figures. The results provide a crucial update on the company's current operational performance and financial trajectory.
Niki BioSolutions President Alidad Mireskandari presented an updated corporate overview and provided forward-looking updates during the H.C. Wainwright Global Investment Conference…
Moleculin announced data presentations on Annamycin at three cancer conferences, focusing on its mechanism, organ distribution, and interaction with the immune system in pancreatic…
QVC Group reported a $200.6 million cash balance at the end of July 2026, after filling $455.5 million in disbursements and $337.6 million in receipts over the previous four months…